The increase in self-administered drugs is part of an even larger shift towards a more patient-centric approach to the production of integrated delivery systems.
Because of this renewed focus on the patient, drug delivery system manufacturers are continually re-evaluating the processes by which they improve existing systems and how they develop new ones.
As a result, delivery system manufacturers have become an invaluable partner to pharmaceutical companies.